<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565734</url>
  </required_header>
  <id_info>
    <org_study_id>CSM-I 07</org_study_id>
    <nct_id>NCT00565734</nct_id>
  </id_info>
  <brief_title>Surgical Treatment of Cervical Spondylotic Myelopathy</brief_title>
  <official_title>An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AO Clinical Investigation and Documentation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AOSpine International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AO Clinical Investigation and Documentation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purposes of this study are to compare anterior and posterior surgical approach in
      treatment of CSM ad to compare variations in treatment and outcomes of CSM worldwide.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical complications and neurological, functional, disease-specific and quality of life measures</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in patient presentation, treatment approaches and treatment outcomes among ethnic/racial groups, health care systems and regions of the world</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">479</enrollment>
  <condition>Cervical Spondylotic Myelopathy</condition>
  <arm_group>
    <arm_group_label>Posterior surgical approaches</arm_group_label>
    <description>Posterior surgical approaches for symptomatic cervical spondylotic myelopathy (CSM)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anterior surgical approaches</arm_group_label>
    <description>Anterior surgical approaches for symptomatic cervical spondylotic myelopathy (CSM).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with symptomatic CSM who referred for surgical consultation to the corresponding
        participating site's orthopedic or neurosurgery services will be eligible for this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Willing and able to give written informed consent to participate in the study

          -  Willing and able to participate in the study follow-up according to the protocol

          -  Willing and able to comply with post-operative management program

          -  Understand and read country language at elementary level

          -  Patients who undergo surgery for symptomatic CSM defined as a combination of one or
             more of the following symptoms:

          -  Numb hands

          -  Clumsy hands

          -  Impairment of gait

          -  Bilateral arm paresthesiae

          -  l'Hermitte's phenomena

          -  Weakness

        AND one or more of the following signs:

          -  Corticospinal distribution motor deficits

          -  Atrophy of hand intrinsic muscles

          -  Hyperreflexia

          -  Positive Hoffman sign

          -  Upgoing plantar responses

          -  Lower limb spasticity

          -  Broad based, unstable gait

        Exclusion Criteria:

          -  Asymptomatic CSM

          -  Previous surgery for CSM

          -  Active infection

          -  Neoplastic disease

          -  Rheumatoid arthritis

          -  Ankylosing spondylitis

          -  Trauma

          -  Concomitant symptomatic lumbar stenosis

          -  Pregnant women or women planning to get pregnant during the study period

          -  Has a history of substance abuse (recreational drugs, alcohol)

          -  Is a prisoner

          -  Is currently involved in a study with similar purpose

          -  Has a disease process that would preclude accurate evaluation (eg., neuromuscular
             disease, significant psychiatric disease)

          -  Patients seen by other services (eg., physical medicine, neurology, family practice),
             managed conservatively and not referred for surgical consultation are ineligible.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Fehlings, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Troronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Univerity of Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2007</study_first_submitted>
  <study_first_submitted_qc>November 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2007</study_first_posted>
  <last_update_submitted>March 5, 2015</last_update_submitted>
  <last_update_submitted_qc>March 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Diseases</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

